Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Umbilical cord ulceration-intestinal atresia syndrome is characterized by congenital intestinal atresia, umbilical cord ulceration and severe intrauterine hemorrhage.
Biomarker and diagnostic research for umbilical cord ulceration-intestinal atresia syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for umbilical cord ulceration-intestinal atresia syndrome.
47 publications have been identified in PubMed for umbilical cord ulceration-intestinal atresia syndrome. Research spans Case Report / Case Series (34%), Epidemiology / Natural History (32%), and Review / Meta-Analysis (19%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 16 | 34% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:41 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression |
15 |
32% |
Research summaries | 9 | 19% |
Laboratory research | 4 | 9% |
Testing and diagnosis research | 2 | 4% |
New treatment approaches | 1 | 2% |
Liu Q (2026). [PMID: 41771684](https://pubmed.ncbi.nlm.nih.gov/41771684/). *J Matern Fetal Neonatal Med*. [Epidemiology / Natural History]
Kim HB (2026). [PMID: 42024537](https://pubmed.ncbi.nlm.nih.gov/42024537/). *Int J Radiat Biol*. [Gene Therapy / Novel Therapeutics]
Bora G (2026). [PMID: 41704145](https://pubmed.ncbi.nlm.nih.gov/41704145/). *Exp Clin Transplant*. [Case Report / Case Series]
Nishinosono T (2026). [PMID: 41902846](https://pubmed.ncbi.nlm.nih.gov/41902846/). *J Clin Immunol*. [Epidemiology / Natural History]
Wu Y (2026). [PMID: 41603709](https://pubmed.ncbi.nlm.nih.gov/41603709/). *Int J Gynaecol Obstet*. [Diagnostic / Biomarker]
Heydari A (2026). [PMID: 42082986](https://pubmed.ncbi.nlm.nih.gov/42082986/). *J Med Case Rep*. [Case Report / Case Series]
Yazawa O (2026). [PMID: 41891914](https://pubmed.ncbi.nlm.nih.gov/41891914/). *Congenit Anom (Kyoto)*. [Diagnostic / Biomarker]
Ramos FS (2026). [PMID: 42032691](https://pubmed.ncbi.nlm.nih.gov/42032691/). *J Transl Med*. [Review / Meta-Analysis]
Portela Carvalho C (2026). [PMID: 41720498](https://pubmed.ncbi.nlm.nih.gov/41720498/). *BMJ Case Rep*. [Case Report / Case Series]
Mu Y (2026). [PMID: 42253842](https://pubmed.ncbi.nlm.nih.gov/42253842/). *Int J Womens Health*. [Case Report / Case Series]